Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
The current price of Abbott Laboratories in the market is 76,52 €, with a 24-hour trading volume of 232,06M €. The asset's market cap is 132,85B €, after moving -0.73% in the last day.
Tokenized Abbott Laboratories is trading at 77,27 €, with a tokenized market cap of 10,89M € and a 24-hour trading volume of 1,51M €. The tokenized asset has moved -0.32% in the past 24 hours.